Filter by Industry
Filter by Topic
Top 10 largest health systems in the U.S.
Discover the largest health systems in the U.S. by number of affiliated hospitals, bed count, and net patient revenue. Boost your sales and marketing…
The race to turn aging science into medicine
The next major frontier in life sciences may be aging itself, as researchers and drug developers look beyond individual age-related diseases to the…
What's next for healthcare marketing? 4 lessons from HCIC 2026
Explore four key takeaways from HCIC 2026 on AI adoption, patient search, marketing attribution, and connected data to inform your healthcare…
AI reshapes online search behavior and marketing strategies
Google’s AIOs and LLMs like ChatGPT are shifting search behavior. Here’s what healthcare marketers are doing about it and how you can stay ahead.
The rise of AI-enabled medical devices
Learn how the rise of AI-enabled medical devices is poised to reshape both the quality of care for patients and the experience of care delivery for…
Turn healthcare expertise into audience reach with KOL data
With the addition of KOL data to Definitive Healthcare’s Digital Audiences, organizations can now seamlessly integrate expert audience intelligence…
Navigate the maze of healthcare with the right approach to data
Definitive Healthcare’s connected healthcare intelligence is an alternative to standalone datasets, bringing critical insights together to help…
2027 trends to watch: AI will put healthcare data foundations to the test
As healthcare organizations bring AI into more workflows, fragmented data, missing context, and weak governance could limit its impact. In 2027…
2027 trends to watch: A growing older population will intensify the burden of age-related disease
America’s growing older population has serious implications for healthcare, especially in the management of progressive and chronic conditions. Learn…
Fierce Pharma Week 2026: 4 takeaways for life sciences leaders
Explore four key takeaways from Fierce Pharma Week 2026, including AI adoption, patient-driven science, GLP-1 engagement, and HCP targeting.